Paul Robbins

281 ‒ Longevity drugs, aging biomarkers, and updated findings from the Interventions Testing Program

Peter Attia MD

Along with Jim Kirkland and Tammeron, suggested Fisetin for ITP testing as a senolytic drug, and later helped evaluate senescent cell markers.